Lindner Research Center | The Christ Hospital | Evolve 48

For Information About Current Clinical Trials
513-585-1777 513-585-1737 (Physician Referral Line) LindnerTrials@TheChristHospital.com

Evolve 48

Enroll Your Patient Now Accepting

Clinical Trials

Evolve 48

The purpose of the study is to assess the FDA requirement for safety and effectiveness of the Synergy 48 mm drug eluding coronary stent system.

Please use this link for further information:

clinicaltrials.gov

Primary Investigator: Steven Rudick

Disclaimer: Patients must have an existing, documented diagnosis to be entered into some trials.
Copyright © 2022 All rights reserved. | Privacy Practices

Web Design by TBH Creative